SAN DIEGO, June 25 – Viaken Systems has received $13 million in second round equity funding, the company announced Monday.

The Gaithersburg, Maryland, bioinformatics company received the additional funding from several venture capital firms, including lead investor Sterling Venture Partners.

The money will support Viaken for 18 months, Keith Elliston, Viaken CEO, told GenomeWeb.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.